KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.82 $19.54 Friday, 26th Apr 2024 MGNX stock ended at $14.56. This is 1.32% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.31% from a day low at $14.22 to a day high of $15.26.
90 days $12.82 $21.88
52 weeks $4.29 $21.88

Historical MacroGenics prices

Date Open High Low Close Volume
Mar 21, 2024 $15.64 $16.18 $15.37 $15.39 669 113
Mar 20, 2024 $15.53 $15.78 $14.89 $15.39 874 865
Mar 19, 2024 $15.42 $15.77 $14.92 $15.58 1 593 211
Mar 18, 2024 $15.80 $16.37 $15.27 $15.60 1 171 225
Mar 15, 2024 $16.02 $16.75 $15.86 $15.93 4 213 605
Mar 14, 2024 $16.32 $16.75 $15.57 $16.06 2 013 191
Mar 13, 2024 $17.50 $17.62 $15.92 $16.56 1 806 154
Mar 12, 2024 $16.86 $17.82 $16.66 $17.60 1 826 002
Mar 11, 2024 $17.15 $18.13 $16.75 $16.94 1 659 482
Mar 08, 2024 $19.34 $21.49 $16.44 $17.43 4 451 711
Mar 07, 2024 $21.59 $21.79 $20.48 $20.51 1 734 230
Mar 06, 2024 $21.07 $21.88 $20.66 $21.47 1 711 909
Mar 05, 2024 $20.79 $21.33 $20.28 $20.64 2 305 682
Mar 04, 2024 $19.78 $20.80 $19.41 $20.72 2 599 652
Mar 01, 2024 $18.06 $19.39 $18.06 $19.06 2 003 422
Feb 29, 2024 $17.84 $18.60 $17.64 $17.94 1 945 356
Feb 28, 2024 $17.22 $17.81 $17.03 $17.19 825 272
Feb 27, 2024 $16.99 $18.52 $16.41 $17.26 1 506 170
Feb 26, 2024 $18.00 $18.47 $16.55 $16.81 1 738 660
Feb 23, 2024 $17.13 $18.19 $17.13 $18.14 1 022 144
Feb 22, 2024 $17.13 $18.45 $16.97 $17.11 892 187
Feb 21, 2024 $17.03 $17.34 $16.80 $17.04 642 964
Feb 20, 2024 $17.13 $17.61 $16.89 $17.17 833 367
Feb 16, 2024 $17.27 $17.49 $16.85 $17.28 952 714
Feb 15, 2024 $16.89 $17.70 $16.33 $17.40 1 058 416
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT